American Society of Clinical Psychopharmacology Annual meeting
May 30 - June 2, 2023
Miami, Florida
Clinical Posters
The scientific posters accessible via this website have been developed and financially supported by Sumitomo Pharma America, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc.
Copies of posters obtained through this site are for personal use only and may not be reproduced without written permission from the authors.
REVIEW OF THE TAAR1 AGONIST ULOTARONT: PART I - FROM DISCOVERY TO CLINIC.
S.C. Hopkins, N. Dedic, C. Zeni, C. Synan, K.S. Koblan.
Download the PDF: CLICK HERE
REVIEW OF THE TAAR1 AGONIST ULOTARONT: PART II - SUMMARY OF INITIAL CLINICAL EFFICACY/SAFETY RESULTS
S.C. Hopkins, H. Dworak, C. Zeni, K.S. Koblan.
Download the PDF: CLICK HERE
THE PHARMACODYNAMIC EFFECTS OF TAAR1 AGONIST ULOTARONT ON METABOLIC BIOMARKERS OF GLUCOSE, C-PEPTIDE AND INSULIN FOLLOWING A MEAL IN PATIENTS WITH SCHIZOPHRENIA
Snezana Milanovic, Yu-Luan Chen1, Kuangnan Xiong, Seth C. Hopkins, Kenneth S. Koblan
Download the PDF: CLICK HERE